TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Generic and Biosimilar Cancer Medicines

Pharmaceutical products
Published value
Not published
Submission deadline Not published
Lots published33
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority"): "Generic and Biosimilar Cancer Medicines". Published status: complete. Published value: Value not published. 33 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")Scope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority"). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
4.3Bids / Report
26.5% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 151 active published awards; 151 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published21 Apr 2023, 08:53 BST
Last source update21 Apr 2023, 08:53 BST
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
OCIDocds-h6vhtk-0368ee
What is being bought
This Framework Agreement is for the supply of generic and biosimilar cancer medicines to NHS Scotland. The Goods were separated into forty-one (41) categories, each of which is identified as a “Lot”. Full details of each awarded Lot is contained in section II.2 of this Notice.
What changed
From the official release history
  1. tender value changed
    21 Apr 2023, 08:53 BST
  2. Status changed to complete
    21 Apr 2023, 08:53 BST
  3. Official notice release published
    21 Apr 2023, 08:53 BST
  4. Submission deadline changed to published date
    21 Apr 2023, 08:53 BST
  5. Published value updated to £59,145,973
    16 Sept 2022, 08:41 BST
  6. Status changed to active
    16 Sept 2022, 08:41 BST
  7. Official notice release published
    16 Sept 2022, 08:41 BST
  8. Submission deadline changed to 17 Oct 2022, 12:00 BST
    16 Sept 2022, 08:41 BST
  9. Buyer information updated
    16 Sept 2022, 08:41 BST
Lots and requirements (33)
Published by the contracting authority
  • Lot 1 · #1
    Lot 1 Bendamustine Powder For Solution For Infusion
    cancelled
    Published valueNot published
    Supply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #10
    Lot 10 Doxorubicin Hydrochloride Injections
    cancelled
    Published valueNot published
    Supply of Doxorubicin Hydrochloride Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #12
    Lot 12 Fluorouracil 50MG/ML Injection
    cancelled
    Published valueNot published
    Supply of Fluorouracil 50MG/ML Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 4 · #13
    Lot 13 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials
    cancelled
    Published valueNot published
    Supply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 5 · #14
    Lot 14 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials
    cancelled
    Published valueNot published
    Supply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 6 · #17
    Lot 17 Ifosfamide Injection Powder For Reconstitution
    cancelled
    Published valueNot published
    Supply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 7 · #18
    Lot 18 Irinotecan Hydrochloride Injection
    cancelled
    Published valueNot published
    Supply of Irinotecan Hydrochloride Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 8 · #19
    Lot 19 Lanreotide Injection Prefilled Syringes
    cancelled
    Published valueNot published
    Supply of Lanreotide Injection Prefilled Syringes to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 9 · #2
    Lot 2 Capecitabine Tablets
    cancelled
    Published valueNot published
    Supply of Capecitabine Tablets to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 10 · #20
    Lot 20 Methotrexate Without Preservatives Injection
    cancelled
    Published valueNot published
    Supply of Methotrexate Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 11 · #21
    Lot 21 Methotrexate Oral Solution
    cancelled
    Published valueNot published
    Supply of Methotrexate Oral Solution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 12 · #23
    Lot 23 Oxaliplatin Vial Solution
    cancelled
    Published valueNot published
    Supply of Oxaliplatin Vial Solution to NHS Scotland. The Authority has awarded presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 13 · #24
    Lot 24 Paclitaxel Concentrate For Intravenous Infusion
    cancelled
    Published valueNot published
    Supply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 14 · #25
    Lot 25 Temozolomide Capsules
    cancelled
    Published valueNot published
    Supply of Temozolomide Capsules to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 15 · #26
    Lot 26 Vincristine Without Preservatives Injection
    cancelled
    Published valueNot published
    Supply of Vincristine Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 16 · #27
    Lot 27 Vinorelbine Injection
    cancelled
    Published valueNot published
    Supply of Vinorelbine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 17 · #28
    Lot 28 Aprepitant Capsules
    cancelled
    Published valueNot published
    Supply of Aprepitant Capsules to NHS Scotland. Each product line within this Lot was grouped together and awarded to a single Framework Participant.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 18 · #3
    Lot 3 Carboplatin Injection
    cancelled
    Published valueNot published
    Supply of Carboplatin Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 19 · #31
    Lot 31 Octreotide Injection
    cancelled
    Published valueNot published
    Supply of Octreotide Injection. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 20 · #32
    Lot 32 Filgrastim Pre-Filled Syringe
    cancelled
    Published valueNot published
    Supply of Filgrastim Pre-Filled Syringe to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 21 · #33
    Lot 33 Pemetrexed Powder For Solution For Infusion Vials
    cancelled
    Published valueNot published
    Supply of Pemetrexed Powder For Solution For Infusion Vials in various presentations to NHS Scotland. The Authority has awarded this Lot as a single-supplier framework.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 22 · #34
    Lot 34 Pemetrexed (25Mg/Ml) Solution For Infusion Vials
    cancelled
    Published valueNot published
    Supply of Pemetrexed (25Mg/Ml) Solution For Infusion Vials to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 23 · #37
    Lot 37 Etoposide Injection
    cancelled
    Published valueNot published
    Supply of Etoposide Injection to NHS Scotland. The Authority has awarded this Lot as a ranked multi-supplier framework award
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 24 · #38
    Lot 38 Dasatinib Tablets
    cancelled
    Published valueNot published
    Supply of Dasatinib Tablets to NHS Scotland. The Authority has awarded each product line as a multi-supplier ranked framework agreement to 2 framework participants.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 25 · #39
    Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines
    cancelled
    Published valueNot published
    Supply of a number of Generic & Biosimilar Medicines including bevacizumab solution for infusion, doxorubicin liposomal solution for infusion, rituximab solution for infusion, trastuzumab powder for solution for infusion, sorafenib tablets and thalidomide capsules to NHS Scotland. Each product line has been treated as an individual Lot and awarded as a unranked multi-supplier award
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 26 · #4
    Lot 4 Cisplatin Injection
    cancelled
    Published valueNot published
    Supply of Cisplatin Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 27 · #40
    Lot 40 Idarubicin Hydrochloride Solution for Infusion
    cancelled
    Published valueNot published
    Supply of Idarubicin Hydrochloride Solution for Infusion. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 28 · #41
    Lot 41 Single Supplier Generic Medicines
    cancelled
    Published valueNot published
    Supply of a range of generic cancer medicines to NHS Scotland. Each product line has been treated as an individual Lot and awarded to a single Framework Participant.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 29 · #5
    Lot 5 Cyclophosphamide Injection, Powder For Reconstitution
    cancelled
    Published valueNot published
    Supply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 30 · #6
    Lot 6 Cytarabine Injections
    cancelled
    Published valueNot published
    Supply of Cytarabine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 31 · #7
    Lot 7 Dacarbazine Injections
    cancelled
    Published valueNot published
    Supply of Dacarbazine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 32 · #8
    Lot 8 Disodium Folinate Injection
    cancelled
    Published valueNot published
    Supply of Disodium Folinate Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 33 · #9
    Lot 9 Docetaxel Concentrate For Solution For Infusion
    cancelled
    Published valueNot published
    Supply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    21 Apr 2023, 08:53 BST
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Award active
    Not published · Not published
  13. Award active
    Not published · Not published
  14. Award active
    Not published · Not published
  15. Award active
    Not published · Not published
  16. Award active
    Not published · Not published
  17. Award active
    Not published · Not published
  18. Award active
    Not published · Not published
  19. Award active
    Not published · Not published
  20. Award active
    Not published · Not published
  21. Award active
    Not published · Not published
  22. Award active
    Not published · Not published
  23. Award active
    Not published · Not published
  24. Award active
    Not published · Not published
  25. Award active
    Not published · Not published
  26. Award active
    Not published · Not published
  27. Award active
    Not published · Not published
  28. Award active
    Not published · Not published
  29. Award active
    Not published · Not published
  30. Award active
    Not published · Not published
  31. Award active
    Not published · Not published
  32. Award active
    Not published · Not published
  33. Award active
    Not published · Not published
  34. Award active
    Not published · Not published
  35. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £94,841
  36. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £64,942
  37. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £254,428
  38. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £101,239
  39. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £17,172
  40. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £226,125
  41. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £2,785,640
  42. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £360,972
  43. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £55,538
  44. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £193,024
  45. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £346,754
  46. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £748,926
  47. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £117,608
  48. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £132,132
  49. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £54,400
  50. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £116,863
  51. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £135,446
  52. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £1,670,068
  53. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £161,249
  54. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £232,447
  55. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £528,727
  56. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £8,560,798
  57. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £594,456
  58. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £110,072
  59. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £163,444
  60. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £2,531,158
  61. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £11,073,623
  62. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £205,855
  63. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £255,695
  64. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £101,689
  65. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £593,020
  66. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £442,064
  67. Contract active
    Signed 23 Dec 2022, 00:00 GMT · £319,866
Commercial outcome and competition
Awards
Accord-UK Ltd
Not published · Not published · active
medac Pharma LLP
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Consilient Health Ltd
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Mercury Pharma Group
Not published · Not published · active
medac Pharma LLP
Not published · Not published · active
Rosemont Pharmaceuticals Ltd
Not published · Not published · active
Ranbaxy (UK) Ltd
Not published · Not published · active
Fresenius Kabi Ltd
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Ranbaxy (UK) Ltd
Not published · Not published · active
Teva UK Limited
Not published · Not published · active
medac Pharma LLP
Not published · Not published · active
Zentiva Pharma UK Ltd
Not published · Not published · active
Ranbaxy (UK) Ltd
Not published · Not published · active
Sandoz Ltd
Not published · Not published · active
Ranbaxy (UK) Ltd
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Teva UK Limited, Zentiva Pharma UK Ltd
Not published · Not published · active
Accord-UK Ltd, Baxter Healthcare Ltd, Celltrion Healthcare United Kingdom Limited, Organon Pharmaceutical UK Ltd, Pfizer Ltd, Roche Products Ltd, Sandoz Ltd, Teva UK Limited, Thornton & Ross, Zentiva Pharma UK Ltd
Not published · Not published · active
Consilient Health Ltd
Not published · Not published · active
Pfizer Ltd
Not published · Not published · active
Accord-UK Ltd, Consilient Health Ltd, Fresenius Kabi Ltd
Not published · Not published · active
Baxter Healthcare Ltd
Not published · Not published · active
Accord-UK Ltd, Aspen Pharmacare UK Limited, Baxter Healthcare Ltd, Bayer Plc, Chugai Pharma UK Ltd, Dr Reddy's Laboratories (UK) Ltd, Flexipharm Austrading Limited, Fresenius Kabi Ltd, Glenmark Pharmaceuticals Europe Ltd, Intrapharm Laboratories Ltd, Kent Pharmaceuticals Ltd, Martindale Pharma, Mercury Pharma Group, Morningside Pharmaceuticals Limited, Neon Healthcare
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Sandoz Ltd
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
medac Pharma LLP
Not published · Not published · active
medac Pharma LLP
Not published · Not published · active
Consilient Health Ltd
Not published · Not published · active
Contracts
Lot 1 Bendamustine Powder For Solution For Infusion
£94,841 · signed 23 Dec 2022, 00:00 GMT · active
Lot 10 Doxorubicin Hydrochloride Injections
£64,942 · signed 23 Dec 2022, 00:00 GMT · active
Lot 12 Fluorouracil 50MG/ML Injection
£254,428 · signed 23 Dec 2022, 00:00 GMT · active
Lot 13 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials
£101,239 · signed 23 Dec 2022, 00:00 GMT · active
Lot 14 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials
£17,172 · signed 23 Dec 2022, 00:00 GMT · active
Lot 18 Irinotecan Hydrochloride Injection
£226,125 · signed 23 Dec 2022, 00:00 GMT · active
Lot 19 Lanreotide Injection Prefilled Syringes
£2,785,640 · signed 23 Dec 2022, 00:00 GMT · active
Lot 20 Methotrexate Without Preservatives Injection
£360,972 · signed 23 Dec 2022, 00:00 GMT · active
Lot 21 Methotrexate Oral Solution
£55,538 · signed 23 Dec 2022, 00:00 GMT · active
Lot 23 Oxaliplatin Vial Solution
£193,024 · signed 23 Dec 2022, 00:00 GMT · active
Lot 24 Paclitaxel Concentrate For Intravenous Infusion
£346,754 · signed 23 Dec 2022, 00:00 GMT · active
Lot 2 Capecitabine Tablets
£748,926 · signed 23 Dec 2022, 00:00 GMT · active
Lot 25 Temozolomide Capsules
£117,608 · signed 23 Dec 2022, 00:00 GMT · active
Lot 26 Vincristine Without Preservatives Injection
£132,132 · signed 23 Dec 2022, 00:00 GMT · active
Lot 27 Vinorelbine Injection
£54,400 · signed 23 Dec 2022, 00:00 GMT · active
Lot 28 Aprepitant Capsules
£116,863 · signed 23 Dec 2022, 00:00 GMT · active
Lot 31 Octreotide Injection
£135,446 · signed 23 Dec 2022, 00:00 GMT · active
Lot 32 Filgrastim Pre-Filled Syringe
£1,670,068 · signed 23 Dec 2022, 00:00 GMT · active
Lot 33 Pemetrexed Powder For Solution For Infusion Vials
£161,249 · signed 23 Dec 2022, 00:00 GMT · active
Lot 34 Pemetrexed (25Mg/Ml) Solution For Infusion Vials
£232,447 · signed 23 Dec 2022, 00:00 GMT · active
Lot 38 Dasatinib Tablets
£528,727 · signed 23 Dec 2022, 00:00 GMT · active
Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines
£8,560,798 · signed 23 Dec 2022, 00:00 GMT · active
Lot 3 Carboplatin Injection
£594,456 · signed 23 Dec 2022, 00:00 GMT · active
Lot 40 Idarubicin Hydrochloride Solution for Infusion
£110,072 · signed 23 Dec 2022, 00:00 GMT · active
Lot 37 Etoposide Injection
£163,444 · signed 23 Dec 2022, 00:00 GMT · active
Lot 17 Ifosfamide Injection Powder For Reconstitution
£2,531,158 · signed 23 Dec 2022, 00:00 GMT · active
Lot 41 Single Supplier Generic Medicines
£11,073,623 · signed 23 Dec 2022, 00:00 GMT · active
Lot 4 Cisplatin Injection
£205,855 · signed 23 Dec 2022, 00:00 GMT · active
Lot 5 Cyclophosphamide Injection, Powder For Reconstitution
£255,695 · signed 23 Dec 2022, 00:00 GMT · active
Lot 6 Cytarabine Injections
£101,689 · signed 23 Dec 2022, 00:00 GMT · active
Lot 7 Dacarbazine Injections
£593,020 · signed 23 Dec 2022, 00:00 GMT · active
Lot 8 Disodium Folinate Injection
£442,064 · signed 23 Dec 2022, 00:00 GMT · active
Lot 9 Docetaxel Concentrate For Solution For Infusion
£319,866 · signed 23 Dec 2022, 00:00 GMT · active
Bid statistics
bids: 4 (lot 1)
electronicBids: 4 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromNonEU: 4 (lot 1)
smeBids: 0 (lot 1)
bids: 3 (lot 10)
electronicBids: 3 (lot 10)
foreignBidsFromEU: 0 (lot 10)
foreignBidsFromNonEU: 3 (lot 10)
smeBids: 0 (lot 10)
bids: 2 (lot 12)
electronicBids: 2 (lot 12)
foreignBidsFromEU: 0 (lot 12)
foreignBidsFromNonEU: 2 (lot 12)
smeBids: 0 (lot 12)
bids: 3 (lot 13)
electronicBids: 3 (lot 13)
foreignBidsFromEU: 0 (lot 13)
foreignBidsFromNonEU: 3 (lot 13)
smeBids: 0 (lot 13)
bids: 1 (lot 14)
electronicBids: 1 (lot 14)
foreignBidsFromEU: 0 (lot 14)
foreignBidsFromNonEU: 1 (lot 14)
smeBids: 0 (lot 14)
bids: 4 (lot 17)
electronicBids: 4 (lot 17)
foreignBidsFromEU: 0 (lot 17)
foreignBidsFromNonEU: 4 (lot 17)
smeBids: 0 (lot 17)
bids: 5 (lot 18)
electronicBids: 5 (lot 18)
foreignBidsFromEU: 0 (lot 18)
foreignBidsFromNonEU: 5 (lot 18)
smeBids: 0 (lot 18)
bids: 1 (lot 19)
electronicBids: 1 (lot 19)
foreignBidsFromEU: 0 (lot 19)
foreignBidsFromNonEU: 1 (lot 19)
smeBids: 0 (lot 19)
bids: 3 (lot 2)
electronicBids: 3 (lot 2)
foreignBidsFromEU: 0 (lot 2)
foreignBidsFromNonEU: 3 (lot 2)
smeBids: 0 (lot 2)
bids: 2 (lot 20)
electronicBids: 2 (lot 20)
foreignBidsFromEU: 0 (lot 20)
foreignBidsFromNonEU: 2 (lot 20)
smeBids: 0 (lot 20)
Buyer and organisations in this procedure

The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")

Contracting authority GB-FTS-4546
View buyer profile
  • The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
    buyer
    centralPurchasingBody

    Gyle Square (NSS Head Office), 1 South Gyle Crescent, Edinburgh, UKM, EH12 9EB
    +44 1698794410
  • Accord-UK Ltd
    supplier

    Whiddon Valley, Barnstaple, Devon, UKK43, EX32 8NS
  • Aspen Pharmacare UK Limited
    supplier

    OFFICE 419-420 4TH FLOOR ONE KINGDOM STREET, Paddington, London, UK, W26bd
  • Baxter Healthcare Ltd
    supplier

    Wallingford Road, Compton,, Newbury, Berkshire, UK, RG20 7QW
  • Bayer Plc
    supplier

    400 South Oak Way, Reading, UKJ11, RG2 6AD
  • Celltrion Healthcare United Kingdom Limited
    supplier

    1-7 The Switch, Slough, UK, SL1 1QP
  • Chugai Pharma UK Ltd
    supplier

    2nd Floor, Mulliner House, Flanders Road, Turnham Green, UK, W4 1NN
  • Consilient Health Ltd
    supplier

    No. 1 Church Road , Richmond upon Thames ., Richmond, UK, TW9 2QE
  • Dr Reddy's Laboratories (UK) Ltd
    supplier

    410, Cambridge Science Park,, Milton Road, Milton,, Cambridge, UK, CB4 0PE
  • Edinburgh Sheriff Court
    reviewBody

    Sheriff Court House, 27 Chambers Street, Edinburgh, EH1 1LB
    +44 1312252525
  • Flexipharm Austrading Limited
    supplier

    ATI House, 6 Boston Drive, Bourne End, UK, SL8 5YS
  • Fresenius Kabi Ltd
    supplier

    Cestrian Court, Eastgate Way,, Manor Park, Runcorn, Cheshire, Runcorn, UK, WA7 1NT
  • Glenmark Pharmaceuticals Europe Ltd
    supplier

    Building 2, Croxley Green Business Park, Watford, UK, WD18 8YA
  • Intrapharm Laboratories Ltd
    supplier

    The Granary, The Courtyard Barns, Choke Lane,, Maidenhead, UK, SL6 6PT
  • Kent Pharmaceuticals Ltd
    supplier

    Joshna House, Crowbridge Road, Ashford, UK, TN24 0GR
  • Martindale Pharma
    supplier

    Bampton Road, Harold Hill, Romford, UK, RM3 8UG
  • Mercury Pharma Group
    supplier

    No.1 Croydon, 12-16 Addiscombe Road, Croydon, UK, CR0 0XT
  • Morningside Pharmaceuticals Limited
    supplier

    5 Pavilion Way, Castle Business Park, Loughborough, Leicestershire, UK, LE11 5GW
  • Neon Healthcare
    supplier

    8 The Chase, John Tate Road, Foxholes Business Park, Hertford, UKH2, SG13 7NN
  • Organon Pharmaceutical UK Ltd
    supplier

    Hertford Road, Hoddesdon, Hertfordshire, Hoddesdon,, Hertfordshire, UK, EN11 9BU
  • Pfizer Ltd
    supplier

    Walton Oaks, Dorking Road, Tadworth, UK, KT20 7NS
  • Ranbaxy (UK) Ltd
    supplier

    Building 4, Chiswick Park, 566 Chiswick High Road, London, UK, W4 5YE
  • Roche Products Ltd
    supplier

    6 Falcon Way, Shire Park, Welwyn Garden City, UK, AL7 1TW
  • Rosemont Pharmaceuticals Ltd
    supplier

    Braithwaite Street, Leeds, West Yorkshire, Leeds, UK, LS11 9XE
  • Sandoz Ltd
    supplier

    Frimley Business Park, Frimley, Camberley, UK, GU16 7SR
  • Selective Supplies Ltd
    supplier

    The Priory, Syresham Gardens, Haywards Heath, UK, RH16 3LB
  • Teva UK Limited
    supplier

    Ridings Point, Whistler Drive, Castleford, UK, WF10 5HX
  • Thornton & Ross
    supplier

    Linthwaite, Huddersfield, UK, HD7 5QH
  • Viatris UK Healthcare Ltd
    supplier

    Building 4, Trident Place, Mosquito Way, Hatfield, UKH23, AL10 9UL
  • Zentiva Pharma UK Ltd
    supplier

    12 New Fetter Lane, london, UK, EC4A 1JP
  • medac Pharma LLP
    supplier

    Scion House, Innovation Park, Stirling, UK, FK9 4NF
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published